Introduction
Fractures are relatively common in healthy children, probably related to high levels of physical activity during childhood [1]. In one British study, around one-third of all children experienced at least one fracture before the age of 17 years [2]. A study in South Africa reported fracture incidence rates of 12–38 per 1000 children per year with higher rates in boys above the age of 10 years, likely due to greater physical risk-prone activities [3]. Childhood fractures impact daily activities, with upper limb fractures (the most common fracture site) leading to an average of 14 activity restricted days per child in high-income countries; similarly lower limb fractures are responsible for on average 26 activity restricted days [4].
As well as activities that may put individuals at risk of injury, impairments in bone architecture and quality may increase fracture risk. In high-income settings, a number of prospective studies have demonstrated an association between low bone mass and childhood fracture risk [1], for example in a UK community-based cohort study, a one standard deviation (SD) reduction in bone mass was associated with an 89% [odds ratio (OR) 1.89, 95% confidence interval (CI) 1.18, 3.04, P = 0.009] increased fracture risk [5].
In sub-Saharan Africa (SSA), up to 50% of children with perinatally acquired HIV infection experience stunting [6], and we have shown evidence of marked deficits in size-adjusted bone-density among peri-pubertal children living with HIV (CLWH) in Zimbabwe [7]. It is currently unclear whether the low bone mass seen in CLWH [7–9], confers an increase in fracture risk. Recent data from the United States suggest fracture incidence is higher in CLWH, but only in those younger than 6 years [10]. Certainly, fracture rates are higher in adults living with HIV compared to the general population [11,12]. Hence, this study aimed to determine the prevalence of fractures in CLWH, to explore the relationship between bone density and fracture prevalence, and to understand the extent to which fractures are associated with functional impairment and disabilities.
Materials and methods
Study design and participants
A cross-sectional study, using baseline data from the IMVASK study (The IMpact of Vertical HIV infection on child and Adolescent SKeletal development in Harare, Zimbabwe), was conducted as per published protocol (ISRCTN12266984) [13]. The bone density findings have been published previously [7]. CLWH, aged 8–16 years, were recruited from outpatient HIV clinics at the two large public-sector general hospitals in Harare (Sally Mugabe and Parirenyatwa Hospitals). Paediatric studies suggest antiretroviral therapy (ART) initiation prompts an initial decline in bone mass which stabilizes after two years [14], hence we enrolled CLWH who had been taking ART for at least 2 years. Systematic quota-based sampling, stratified by age and sex, was used to recruit 50 male and 50 female CLWH in each of three age-groups (8–10, 11–13 and 14–16 years). Exclusion criteria included being acutely unwell (defined as requiring immediate hospitalization), not residing in Harare and children being unaware of their HIV status (to avoid inadvertent disclosure through study participation). A maximum of five CLWH were recruited each day for logistical reasons.
For comparison, children without HIV were recruited from six government primary and secondary schools randomly selected from the 109 primary and 44 secondary schools within the same catchment areas in Harare served by the hospitals. Younger children (8–12 years) were sampled from primary schools and older children (14–16 years) from secondary schools, with 13-year-olds sampled from both school types. The number of children selected from each school was proportional to school size, giving each child equal probability of being sampled. A random number sequence applied to school registers was employed to select participants using the same quota-based sampling approach of 50 males and 50 females in each of the three age strata (8–10, 11–13 and 14–16 years). Children underwent HIV testing before recruitment, and those testing positive and not in care were referred to HIV services.
Study questionnaire
An interviewer-administered questionnaire was used to collect sociodemographic data and information regarding self-recalled fractures sustained since birth, from children and caregivers. Details of the fracture site and clinical management were recorded. The International Physical Activity Questionnaire (IPAQ), validated in multiple countries including South Africa, assessed physical activity as multiples of the resting metabolic rate (MET) in MET-minutes [15]. Diet and nutrition were assessed using a tool based on a validated dietary diversity and food frequency tool from India and Malawi, adapted to the Zimbabwean context, using international guidelines applicable to SSA [16]. This tool quantified dietary calcium and vitamin D intake, plus sunlight exposure; adaptations reflected the local context where fortification of oils and margarine with vitamin D is mandated and specific calcium and vitamin D rich foods, for example, kapenta fish, are commonly eaten.
Anthropometry
Anthropometric measurements were carried out by trained research staff. Standing and sitting height, measured to the nearest 0.1 cm (using a Seca 213 stadiometer), and weight (using Seca 875 weight scales), measured to the nearest 0.1 kg, were taken by two separate readers. If height measurements differed by more than 0.5 cm, or weight measurements by more than 0.5 kg, a third reading was taken, and final height and weight values were taken as means of the two or three measurements. The same researchers measured both the children with and without HIV. All equipment was calibrated annually.
HIV assessment
Details about HIV including age at HIV diagnosis, ART regimen and duration were collected from hand-held medical records during the interviewer-administered questionnaire for CLWH. CD4+ cell count was measured using an Alere PIMA CD4 machine (Waltham, Massachusetts, USA) and HIV viral load using the GeneXpert HIV-1 viral load platform (Cepheid Inc., Sunnyvale, California, USA), with viral suppression defined as <1000 copies/ml as per WHO guidelines [17].
Dual energy X-ray absorptiometry scanning
Dual-energy X-ray absorptiometry (DXA) scans of the lumbar spine and total body were performed by one of two trained radiographers using standard procedures on a Hologic QDR Wi densitometer (Hologic Inc., Bedford, Massachusetts, USA) with Apex Version 4.5 software for scan analysis. The manufacturer provided spine phantom was used daily for calibration. DXA scans were repeated in a subgroup (n = 30) to determine reproducibility. The precision error was a root mean square-standard deviation (RMS-SD) of 0.011 g/cm2 (lumbar spine) and 0.010 g/cm2 (total body) with an RMS-coefficient of variation (CV) of 1.35% (lumbar spine) and 1.22% (total body). An important limitation of DXA in paediatric populations with chronic disease is that the two-dimensional (areal) bone density values are highly dependent upon body, and therefore bone size; hence DXA underestimates bone density in small children [18]. The two main size adjustment techniques recommended by the International Society for Clinical Densitometry (ISCD) to overcome the problem of size dependence of DXA measurement [19], were employed, that is to measure total-body less-head (TBLH) bone mineral content (BMC) for lean mass adjusted for height (TBLH-BMCLBM) and lumbar spine bone mineral apparent density (low size-adjusted bone density [LS-BMAD]). LS-BMAD was calculated from DXA-measured lumbar spine data using the Carter method [20]. TBLH-BMCLBM was calculated from the whole-body scan using published derived equations, for Hologic DXAs, which adjust for log-transformed total body lean mass, total body fat mass and height [21]. Sex and age-matched Z-scores were generated using Hologic UK population reference data as recommended by ISCD guidelines, as there were no local reference data available [19]. Low TBLH-BMCLBM and LS-BMAD were defined as Z-score <−2.0 [21].
Statistical analysis
A sample size of 300 in each group was calculated to enable detection of a difference between children with and without HIV in fracture prevalence of 7% (predicted 5% in children without HIV and 12% in CLWH) with 80% power and a significance level of 0.05.
Height-for-age and weight-for-age Z-scores were calculated using 1990 UK reference data [7], with Z-scores <−2.0 defining stunting and underweight respectively. Socio-economic status (SES) was derived using the first component from a principal component analysis combining an asset list (detailing: number in household, home ownership, access to electricity, water, a flush toilet and/or pit latrine and ownership of a bicycle, car, fridge, television, and/or radio), which was categorised into tertiles for analysis.
Analyses were conducted using Stata 17.0 (StatCorp, College Station, Texas, USA). The primary exposure was HIV and primary outcome the prevalence of self-reported fracture. The secondary outcome was the prevalence of disability in those with self-reported fracture. The characteristics of participants with HIV were compared with those without HIV, using independent sample t-tests for means, with unequal variance as required and chi-squared or Fisher's exact tests for proportions. Generalized linear log-binomial modelling was used to determine potential risk factors associated with prevalent fracture, including age [1], male [1], height [22], underweight [23], more physically active [24], living with HIV [25], reporting low calcium [26] and vitamin D intake [27], socio-economic deprivation indicated by low SES [28] and/or orphanhood [7]. A generalized linear log-binomial model was used to assess the association between size-adjusted bone density and prevalent fracture adjusting for age and sex.
Ethical considerations
Ethical approvals were granted by the Medical Research Council of Zimbabwe (Ref: MRCZ/A/2297), the Institutional Review Board of the Biomedical Research and Training Institute in Harare (Ref: AP145/2018), the Joint Research Ethics Committee for University of Zimbabwe Faculty of Medicine and Health Sciences and the Parirenyatwa Group of Hospitals (Ref: 11/18), Sally Mugabe (formally Harare Central) Hospital Ethics Committee (Ref: 170118/04), and the London School of Hygiene & Tropical Medicine Ethics Committee (Ref: 15333). Parents/guardians provided written informed consent for study participation and HIV testing, and children provided written assent.
Results
Study population
We recruited 303 children living with HIV (CLWH) [mean (SD) age 12.5 (2.5) years; 50% female] and 306 children without HIV [mean (SD) age 12.5 (2.5) years; 51% female]. As previously reported, CLWH were more likely to be in the lowest socioeconomic tertile, orphaned (one or both parents dead) and to report lower levels of physical activity compared with children without HIV [7]. Reported dietary calcium and vitamin D intakes were similar between CLWH and children without HIV. Amongst CLWH, the median age at HIV diagnosis was 3.0 years [interquartile range (IQR) 1.2, 5.9], with median ART duration being 8.1 years [IQR 6.2, 9.5]; in 34% of cases, ART included tenofovir (Table 1).
Table 1 -
Socio-demographic, lifestyle and HIV characteristics of study participants.
|
|
HIV positive |
HIV negative |
P-value |
|
|
N
|
n (%)a
|
N
|
n (%)a
|
|
Socio-demographic factors
|
Age years, mean (SD) |
303 |
12.5 (2.5) |
306 |
12.5 (2.5) |
0.793 |
|
Female sex |
303 |
151 (49.8) |
306 |
155 (50.7) |
0.840 |
|
Socioeconomic status (SES) |
303 |
|
306 |
|
0.005 |
|
Tertile 1 (low) |
|
115 (38.0) |
|
88 (28.8) |
|
|
Tertile 2 (middle) |
|
105 (34.7) |
|
98 (32.0) |
|
|
Tertile 3 (high) |
|
83 (27.4) |
|
120 (39.2) |
|
|
Orphaned (one or both parents dead) |
297b
|
130 (43.8) |
303 |
20 (6.6) |
<0.001 |
|
In school |
303 |
299 (98.7) |
306 |
306 (100) |
0.06 |
Lifestyle factors
|
Physical activity level |
303 |
|
306 |
|
0.012 |
|
Low, <600 MET min/week |
|
148 (48.8) |
|
114 (37.3) |
|
|
Moderate, 600–3000 MET min/week |
|
77 (25.4) |
|
88 (28.8) |
|
|
High, >3000 MET min/week |
|
78 (25.7) |
|
104 (34.0) |
|
|
Daily dietary calcium intake |
303 |
|
306 |
|
0.936 |
|
Very low, <150 mg/day |
|
135 (44.6) |
|
136 (44.4) |
|
|
Low, 150–299 mg/day |
|
62 (20.5) |
|
66 (21.6) |
|
|
Moderate, 300–450 mg/day |
|
106 (35.0) |
|
104 (34.0) |
|
|
Daily dietary vitamin D |
303 |
|
306 |
|
0.413 |
|
Very low, <4.0 mcg/day |
|
17 (5.6) |
|
15 (4.9) |
|
|
Low, 4.0–5.9 mcg/day |
|
181 (59.7) |
|
164 (53.6) |
|
|
Moderate, 6.0–10.0 mcg/day |
|
105 (34.7) |
|
127 (41.5) |
|
HIV characteristics
|
Age at HIV diagnosis years, median (IQR) |
303 |
3.0 (1.2–5.9) |
|
|
|
|
Age at ART initiation years, median (IQR) |
303 |
3.7 (1.8–6.9) |
|
|
|
|
ART duration years, median (IQR) |
303 |
8.1 (6.2–9.5) |
|
|
|
|
% life on ART, mean (SD) |
303 |
65.3 (22.0) |
|
|
|
|
Current tenofovir use |
303 |
102 (33.7) |
|
|
|
|
Viral load <1000 copies/ml |
268c
|
212 (79.1) |
|
|
|
|
CD4+ cell count <500 cells/μl |
288d
|
58 (20.1) |
|
|
|
Anthropometry
|
Height-for-age Z-score, mean (SD) |
301e
|
−1.65 (1.12) |
306 |
−0.59 (1.02) |
<0.001 |
|
Height-for-age Z-score <−2 |
301 |
95 (31.6) |
306 |
22 (7.2) |
<0.001 |
|
Weight-for-age Z-score, mean (SD) |
303 |
-1.47 (1.19) |
305f
|
-0.50 (1.09) |
<0.001 |
|
Weight-for-age Z-score <−2 |
303 |
80 (26.4) |
305 |
23 (7.5) |
<0.001 |
an (%) unless stated otherwise.
bOrphan status data was missing for nine participants (6 living with HIV, 3 HIV negative). the child's mother was alive but it was not known whether the father was still alive.
cViral load data was missing in 35 participants with HIV.
dCD4+ data was missing in 15 participants; not fasted so bloods not taken (n = 12), refusal (n = 3).
eMissing height data for two participants with HIV.
fMissing weight data in one child without HIV.
Prevalent fracture by HIV status
Overall, 5.7% of children reported having experienced a fracture, with no difference in prevalence by HIV status [14 out of 303 (4.6%) in CLWH vs. 21 out of 306 (6.9%) in children without HIV; P = 0.235]. The most common fracture site was the arm and/or wrist in both CLWH and those without HIV [10/14 (71.4%) vs. 14/21 (66.7%)] (Fig. 1). Most fractures [31/35 (88.6%)] were confirmed by X-ray and in all cases, medical attention was sought to manage the fracture. Compared to children without HIV, CLWH were less likely to be admitted to hospital with their fracture [2/14 (14.3%) vs. 7/21 (33.3%)] (Figure 1, Supplemental Digital Content, https://links.lww.com/QAD/C790). No child had their fracture managed surgically.
Fig. 1: Prevalent fractures by skeletal site and HIV status.
Self-reported disability
CLWH were more likely than children without HIV to self-report disability and/or functional impairment [163/303 (53.8%) vs. 90/306 (29.4%), chi2 = 37.3, P < 0.001]. CLWH were more likely to have difficulty walking and/or running [25/303 (8.3%) vs. 9/306 (2.9%), chi2 = 8.14, P = 0.004] compared to children without HIV. Difficulties with self-care were few [6/303 (2.0%) vs. 3/306 (1%) in those with and without HIV respectively, P = 0.34], whilst self-reported sensory, memory and speech difficulties were over twice as common in CLWH ([142/303 (46.9%) vs. 61/306 (19.9%), chi2 = 49.7, P < 0.001).
There was no clear evidence that prevalent fracture was associated with all-cause disability or with difficulty walking/running, either in CLWH or children without HIV, or overall (Table 2).
Table 2 -
Relationship between reported disability and prevalent fractures.
|
n
|
Prevalent fracture, n (%) |
Chi square |
P-value |
All children |
 Self-reported disability |
253 |
11 (4.4) |
1.56 |
0.21 |
 No disability |
356 |
24 (6.7) |
|
|
Children with HIV |
 Self-reported disability |
163 |
4 (2.5) |
3.76 |
0.060a
|
 No disability |
140 |
10 (7.1) |
|
|
Children without HIV |
 Self-reported disability |
90 |
7 (7.8) |
0.17 |
0.68 |
 No disability |
216 |
14 (6.5) |
|
|
All children |
 Self-reported difficulty walking/running |
34 |
4 (11.8) |
2.41 |
0.12a
|
 No difficulty |
575 |
31 (5.4) |
|
|
Children with HIV |
 Self-reported difficulty walking/running |
25 |
3 (12.0) |
3.37 |
0.0981
|
 No difficulty |
278 |
11 (4.0) |
|
|
Children without HIV |
 Self-reported difficulty walking/running |
9 |
1 (11.1) |
0.26 |
0.48 |
 No difficulty |
297 |
20 (6.7) |
|
|
Bone density and prevalent fracture
When examined overall, no clear association between low LS-BMAD or TBLH-BMCLBMZ-score with self-reported prevalent fracture was observed. However, when stratified by HIV status, there was weak evidence that CLWH with a low LS-BMAD Z-score had increased risk of self-reported fracture compared to CLWH with normal LS-BMAD (RR 1.14 [−0.02, 2.29], P = 0.053; this association was not seen among children without HIV, P-interaction = 0.27. Only two CLWH reported a prevalent fracture and had a low TBLH-BMCLBMZ-score (Table 3).
Table 3 -
The association between size-adjusted bone density and self-reported prevalent fracture in children living with and without HIV.
|
DXA Z-score <−2 |
DXA Z-score ≥−2 |
RR (95% CI) |
P-value |
aLS-BMAD (n = 576) |
 All children |
5/56 (8.9) |
25/520 (4.8) |
0.62 (−0.31, 1.54) |
0.187 |
 Children with HIV |
4/39 (10.3) |
8/243 (3.3) |
1.14 (−0.02, 2.29) |
0.053 |
 Children without HIV |
1/17 (5.9) |
17/277 (6.1) |
−0.04 (−2.00, 1.91) |
0.966 |
bTBLH-BMCLBM (n = 575) |
 All children |
2/45 (4.4) |
28/530 (5.3) |
−0.17 (−1.57, 1.23) |
0.809 |
 Children with HIV |
2/28 (7.1) |
10/254 (3.9) |
0.60 (−0.87, 2.06) |
0.426 |
 Children without HIV |
0/17 (0.0) |
18/276 (6.5) |
- |
- |
DXA, dual-energy X-ray absorptiometry; LS-BMAD, low size-adjusted bone density; TBLH-BMC, total-body less-head bone mineral content.
aLS BMAD Z-score data is missing for 21 participants with HIV and 12 participants without HIV.
bTBLH-BMCLBMZ-score data is missing for 21 participants with HIV and 13 participants without HIV.
Risk factors for prevalent fracture
Generalized linear log-binomial modelling identified male sex as a risk factor for reporting a prevalent fracture (Table 4). HIV status, SES, orphan status, physical activity, dietary vitamin D and calcium intake, height and weight were not associated with self-reported prevalent fracture after adjusting for age and sex (Table 4). Amongst those with HIV, age of HIV diagnosis, age at ART initiation, ART duration, tenofovir use, viral load and CD4+ cell count were not associated with self-reported prevalent fracture (Table 1, Supplemental Digital Content, https://links.lww.com/QAD/C790).
Table 4 -
Risk factors for reporting a prevalent fracture in all participants.
Risk factor |
Prevalent fracture (n = 35) N (%) |
No prevalent fracture (n = 574) N (%) |
Age/sex adjusted RR (95% CI) |
P-value |
Age |
 <12 years |
12 (4.5) |
255 (95.5) |
Ref |
0.228 |
 ≥12 years |
23 (6.7) |
319 (93.3) |
0.42 (−0.26, 1.09)a
|
|
Sex |
 Male |
23 (7.6) |
280 (92.4) |
Ref |
0.054 |
 Female |
12 (3.9) |
294 (96.1) |
−0.67 (−1.35, 0.01)b
|
|
Socioeconomic status (SES) |
 Tertile 1 (low) |
10 (4.9) |
193 (95.1) |
Ref |
0.268 |
 Tertile 2 (middle) |
9 (4.4) |
194 (95.6) |
−0.14 (−1.02, 0.74) |
|
 Tertile 3 (high) |
16 (7.9) |
187 (92.1) |
0.45 (−0.31, 1.22) |
|
Orphan status (one or both parents dead) |
 Yes |
6 (4.0) |
144 (96.0) |
−0.57 (−1.43, 0.29) |
0.196 |
 No |
29 (6.4) |
421 (93.6) |
Ref |
|
 Missing |
0 (0.0) |
9 (100.0) |
|
|
Physical activity |
|
|
|
|
 Low, <600 MET min/week |
15 (5.7) |
247 (94.3) |
Ref |
0.961 |
 Moderate, 600–3000 MET min/week |
9 (5.5) |
156 (94.5) |
−0.09 (−0.89, 0.71) |
|
 High, >3000 MET min/week |
11 (6.0) |
171 (94.0) |
0.02 (−0.73, 0.78) |
|
Dietary calcium intake |
 <150 mg/day |
15 (5.5) |
256 (94.5) |
−0.03 (−0.77, 0.70) |
0.944 |
 150–299 mg/day |
8 (6.3) |
120 (93.8) |
0.11 (−0.75, 0.97) |
|
 300–449 mg/day |
12 (5.7) |
198 (94.3) |
Ref |
|
Dietary vitamin D intake |
 <6.0 mcg/day |
20 (5.3) |
357 (94.7) |
−0.17 (−1.81, 0.48) |
0.616 |
 ≥6.0 mcg/day |
15 (6.5) |
217 (93.5) |
Ref |
|
Height for age Z-score |
 Stunted (<−2) |
4 (3.4) |
113 (96.6) |
−0.72 (−1.74, 0.30) |
0.167 |
 Not stunted |
31 (6.3) |
459 (93.7) |
Ref |
|
 Missing |
0 (0.0) |
2 (100.0) |
|
|
Weight-for-age Z-score |
 Underweight (<−2) |
8 (7.8) |
95 (92.2) |
0.22 (−0.55, 0.99) |
0.583 |
 Not underweight |
27 (5.4) |
478 (94.6) |
Ref |
|
 Missing |
0 (0.0) |
1 (100.0) |
|
|
HIV status |
 Positive |
14 (4.6) |
289 (95.4) |
−4.26 (−1.08, 0.23) |
0.203 |
 Negative |
21 (6.9) |
285 (93.1) |
Ref |
|
CI, confidence interval; RR, risk ratio.
aRR adjusted for sex only.
bRR adjusted for age only.
Discussion
Our study found a reported fracture prevalence of 5.9% among peripubertal children. Observed fracture patterns were similar to previous reports; upper limb fractures accounting for 65% of fractures [29] and lower limb up to 28% [30]. Fracture risk is explained by both extrinsic activities that put individuals at risk of injury as well as intrinsic factors, that is, skeletal factors such as bone strength, measured as density. The association between male sex and prevalent fracture has been reported in other contexts [1], and may relate to more risk-prone higher impact physical activities pursued by males, such as sport activities [30].
Fracture risk has been poorly studied in children with HIV. While there was no difference in fracture prevalence by HIV status, LS-BMAD appeared to be associated with prevalent fracture in CLWH, but not among uninfected children. Low bone density is a well recognized complication of HIV disease, with a 2.5 times higher odds of osteoporosis and/or osteopenia in adults living with HIV than in HIV-negative peers, including among individuals taking ART [31]. We and others have reported how children with perinatally acquired HIV also have lower bone density for age and sex, compared to HIV-uninfected peers [8,9]. In our study, we used size-adjusted bone density as CLWH often have growth delay, and areal bone density as measured by DXA can underestimate bone density in small children [18].
Growth delay, persistent immune activation and chronic inflammation driven by HIV infection and exposure to certain ART drugs can all affect bone accrual during critical periods of bone development in CLWH. Adolescence is a critical period for bone mass accrual; after cessation of linear growth, consolidation of mineral continues until peak bone mass (PBM) is achieved in early adulthood. Hence, disturbances in growth and bone accrual due to HIV infection have implications for achievement of PBM. Importantly, low PBM predicts adult osteoporotic fracture risk; a 10% reduction in PBM doubles fracture risk in adulthood [32]. Attention to potential fracture risk is therefore warranted in children with HIV reaching adulthood.
Physical activity is thought to have both beneficial and detrimental effects on fracture risk in childhood [1]; on the one hand, skeletal loading providing osteogenic stimulation is beneficial to bone mass [33], whilst injuries from vigorous physical activity can increase fracture risk irrespective of bone mass [24], with high-impact sports further increasing fracture risk [30]. The observed higher fracture prevalence in children without HIV is consistent with the higher levels of physical activity, some of which is expected to be vigorous and/or high impact; although, after adjusting for age and sex, physical activity was not associated with prevalent fracture in our analyses.
HIV-related factors such as CD4+ cell count, viral load and current tenofovir use were not associated with prevalent fractures in CLWH. However, these factors relate to the current point in time while the outcome measures events that may have occurred in the past. Furthermore, the study may have been underpowered to detect associations. In addition to HIV-specific risks, other traditional risk factors for low bone density and fracture include poor nutrition, low physical activity, inadequate dietary calcium intake and vitamin D deficiency. We note that in our study physical activity levels were lower in CLWH, but overall low dietary calcium and vitamin D intakes, as well as physical activity levels, were not associated with prevalent fractures.
We did observe differences in self-reported fracture management by HIV status, despite most fractures being confirmed within a health facility by X-ray, and all cases seeking medical attention for their fracture. CLWH were less likely to receive inpatient fracture care, despite no differences in fracture type by HIV status. This inequality may reflect lack of ability to pay for treatment, as suggested by the substantial differences by HIV status observed in socioeconomic status and warrant further investigation.
Disability was common, particularly in CLWH, in whom just over half reported a disability and/or functional impairment, mostly constituting sensory, memory and/or speech difficulties, as well as 8.3% having difficulty walking and/or running. The analyses were underpowered to detect associations between prevalent fracture and difficulty walking and/or running. The observed levels of self-reported disability were higher than previously reported in a similar Zimbabwean population, in whom 37.6% of 6–16 years old CLWH self-reported a disability, and 2.5% specifically difficulty walking [34]. Even at these previously reported levels, strong associations with impaired educational achievement and social functioning have been reported [34], highlighting the need for relevant support services within paediatric HIV programmes.
Study strengths include a broadly representative HIV-uninfected comparison group, recruited from the same catchment area as CLWH, and collection of detailed data on risk factors such as physical activity, dietary calcium and vitamin D intake using validated tools adapted for the local context. Recommended size-adjustment methods were used for DXA data, which were particularly important given height differences (levels of stunting) in the population studied [19,21]. We acknowledge several limitations: data are cross-sectional and therefore causality cannot be inferred. Fractures were self-reported so subject to recall bias. Given potential recall bias, the timing of fractures was not collected, hence it was not possible to calculate retrospective fracture incidence. Recall bias may be exacerbated among CLWH who are likely to have more experience of medical care. Lack of data on fracture mechanism prevented analysis by trauma level; we also lacked data on prenatal/perinatal HIV exposure in the children without HIV. The study was likely underpowered to detect a difference in fracture prevalence by HIV status, nor to determine an association between fracture and disability. As local or African reference population data are not available, Z-scores for TBLH-BMCLBM and LS-BMAD were generated using data from a paediatric reference population in the UK, using the same manufacturer and software version to derive Z-scores (as recommended by international guidelines [19,21]), who may not be comparable to the children studied in Zimbabwe.
In conclusion, prevalent fractures appear to be associated with low size-adjusted bone density in CLWH. Research is needed to understand barriers to accessing fracture care. Continuing surveillance for fractures is warranted as the current cohorts of CLWH enter adulthood as are strategies to reduce the risk of developing future fractures.
Acknowledgements
The authors thank Dr Nicola Crabtree for her advice regarding calculation of TBLH-BMCLBM and LS-BMAD Z-scores.
Author's contributions: R.R., R.A.F., and C.L.G. conceived the study. R.A.F., C.L.G., R.R. and A.M.R. designed the study protocol. R.R. was responsible for data management. C.M.K. contributed to data collection. A.M.R., C.L.G., V.S. and R.R. conducted data analyses. R.R. wrote the first draft. R.R. and V.S. had full access to all the study data and had final responsibility for the decision to submit for publication. All authors contributed to the report and approved the final submitted text.
Author's information: R.R. (206764/Z/17/Z) and R.A.F. (206316/Z/17/Z) are funded by the Wellcome Trust. C.M.K. is funded by a National Institute of Health (NIH) Fogarty Trent Fellowship. A.M.R. and V.S. are partially supported by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement which is also part of the EDCTP2 programme supported by the European Union Grant Ref: MR/R010161/1.
Conflicts of interest
There are no conflicts of interest.
References
1. Clark EM.
The epidemiology of fractures in otherwise healthy children.
Curr Osteoporos Rep 2014; 12 (3s):272–278.
2. Cooper C, Dennison EM, Leufkens HG, Bishop N, van Staa TP.
Epidemiology of childhood fractures in Britain: a study using the general practice research database.
J Bone Miner Res 2004; 19:1976–1981.
3. Thandrayen K, Norris SA, Pettifor JM.
Fracture rates in urban South African children of different ethnic origins: the birth to twenty cohort.
Osteoporos Int 2009; 20:47–52.
4. Kopjar B, Wickizer TM.
Fractures among children: incidence and impact on daily activities.
Inj Prev 1998; 4:194–197.
5. Clark EM, Ness AR, Bishop NJ, Tobias JH.
Association between bone mass and fractures in children: a prospective cohort study.
J Bone Miner Res 2006; 21:1489–1495.
6. Williams PL, Jesson J.
Growth and pubertal development in HIV-infected adolescents.
Curr Opin HIV AIDS 2018; 13:179–186.
7. Rukuni R, Rehman AM, Mukwasi-Kahari C, Madanhire T, Kowo-Nyakoko F, McHugh G, et al.
Effect of HIV infection on growth and bone density in peripubertal children in the era of antiretroviral therapy: a cross-sectional study in Zimbabwe.
Lancet Child Adolesc Health 2021; 5:569–581.
8. Shen Y, Shiau S, Strehlau R, Burke M, Patel F, Johnson CT, et al.
Persistently lower bone mass and bone turnover among South African children living with well controlled HIV.
AIDS 2021; 35:2137–2147.
9. Gregson CL, Hartley A, Majonga E, McHugh G, Crabtree N, Rukuni R, et al.
Older age at initiation of antiretroviral therapy predicts low bone mineral density in children with perinatally-infected HIV in Zimbabwe.
Bone 2019; 125:96–102.
10. Jacobson DL, Yu W, Hazra R, Brummel S, Geffner ME, Patel K, et al.
Fractures in children and adolescents living with perinatally acquired HIV.
Bone 2020; 139:115515.
11. Gonciulea A, Wang R, Althoff KN, Palella FJ, Lake J, Kingsley LA, et al.
An increased rate of fracture occurs a decade earlier in HIV+ compared with HIV− men.
AIDS 2017; 31:1435–1443.
12. Womack JA, Goulet JL, Gibert C, Brandt C, Chang CC, Gulanski B, et al.
Increased risk of fragility fractures among HIV infected compared to uninfected male veterans.
PLoS One 2011; 6:e17217.
13. Rukuni R, Gregson C, Kahari C, Kowo F, McHugh G, Munyati S, et al.
The IMpact of Vertical HIV infection on child and Adolescent SKeletal development in Harare, Zimbabwe (IMVASK Study): a protocol for a prospective cohort study.
BMJ Open 2020; 10:e031792.
14. Aurpibul L, Cressey TR, Sricharoenchai S, Wittawatmongkol O, Sirisanthana V, Phongsamart W,
et al. Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing.[Erratum appears in
Pediatr Infect Dis J 2015;
34:847],
Pediatr Infect Dis J 2015;
34:392−397.
15. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al.
International physical activity questionnaire: 12-country reliability and validity.
Med Sci Sports Exerc 2003; 35:1381–1395.
16. Filteau S, Rehman AM, Yousafzai A, Chugh R, Kaur M, Sachdev HP, et al.
Associations of vitamin D status, bone health and anthropometry, with gross motor development and performance of school-aged Indian children who were born at term with low birth weight.
BMJ Open 2016; 6:e009268.
17. WHO.
Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring. Geneva: World Health Organization; 2021.
18. Crabtree N, Ward K.
Bone densitometry: current status and future perspective. In: Allgrove J, Shaw NJ, editors.
Calcium and bone disorders in children and adolescents. 2nd, revised ed. Basel: Karger; 2015. pp. 72−83.
19. Crabtree NJ, Arabi A, Bachrach LK, Fewtrell M, El-Hajj Fuleihan G, Kecskemethy HH, et al.
Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions.
J Clin Densitom 2014; 17:225–242.
20. Carter DR, Bouxsein ML, Marcus R.
New approaches for interpreting projected bone densitometry data.
J Bone Miner Res 1992; 7:137–145.
21. Crabtree NJ, Shaw NJ, Bishop NJ, Adams JE, Mughal MZ, Arundel P, et al.
Amalgamated reference data for size-adjusted bone densitometry measurements in 3598 children and young adults-the ALPHABET study.
J Bone Miner Res 2017; 32:172–180.
22. McCormack SE, Cousminer DL, Chesi A, Mitchell JA, Roy SM, Kalkwarf HJ, et al.
Association between linear growth and bone accrual in a diverse cohort of children and adolescents.
JAMA Pediatr 2017; 171:e171769–e1171769.
23. Bialo SR, Gordon CM.
Underweight, overweight, and pediatric bone fragility: impact and management.
Curr Osteoporos Rep 2014; 12:319–328.
24. Clark EM, Ness AR, Tobias JH.
Vigorous physical activity increases fracture risk in children irrespective of bone mass: a prospective study of the independent risk factors for fractures in healthy children.
J Bone Miner Res 2008; 23:1012–1022.
25. Eckard AR, Mora S.
Bone health in HIV-infected children and adolescents.
Curr Opin HIV AIDS 2016; 11:294–300.
26. Goulding A.
Risk factors for fractures in normally active children and adolescents.
Med Sport Sci 2007; 51:102–120.
27. Thompson RM, Dean DM, Goldberg S, Kwasny MJ, Langman CB, Janicki JA.
Vitamin D insufficiency and fracture risk in urban children.
J Pediatr Orthop 2017; 37:368–373.
28. Stark AD, Bennet GC, Stone DH, Chishti P.
Association between childhood fractures and poverty: population based study.
BMJ 2002; 324:457–1457.
29. Lyons RA, Delahunty AM, Kraus D, Heaven M, McCabe M, Allen H, et al.
Children's fractures: a population based study.
Inj Prev 1999; 5:129–132.
30. Wren TA, Shepherd JA, Kalkwarf HJ, Zemel BS, Lappe JM, Oberfield S, et al.
Racial disparity in fracture risk between white and nonwhite children in the United States.
J Pediatr 2012; 161:1035–1040.
31. Goh SSL, Lai PSM, Tan ATB, Ponnampalavanar S.
Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
Osteoporosis Int29:595−613.
32. Hernandez CJ, Beaupré GS, Carter DR.
A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis.
Osteoporos Int 2003; 14:843–847.
33. Detter FT, Rosengren BE, Dencker M, Nilsson J, Karlsson MK.
A 5-year exercise program in pre and peripubertal children improves bone mass and bone size without affecting fracture risk.
Calcif Tissue Int 2013; 92:385–393.
34. Rukuni R, McHugh G, Majonga E, Kranzer K, Mujuru H, Munyati S, et al.
Disability, social functioning and school inclusion among older children and adolescents living with HIV in Zimbabwe.
Trop Med Int Health 2018; 23:149–155.